Indeed, animal studies have demonstrated benefits in treating obesity and diabetes through AAV‐mediated expression of FGF21 or coexpression of insulin and glucokinase genes in skeletal muscles.28, 29, 30. The gene discussed is INS; the disease is Obesity.